Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03887052 · ClinicalTrials.gov registry record · NA
ASSURE WCD Clinical Evaluation - Detection and Safety Study
A NA study, sponsored by Kestra Medical Technologies.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT03887052 is a NA study that has completed, run by Kestra Medical Technologies. The registered enrollment target is 130 participants.
The verdict
NCT03887052, a NA study, has completed, sponsored by Kestra Medical Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
A prospective multicenter single arm open label study to evaluate ambulatory detection performance, arrhythmia detection and safety of the ASSURE™ Wearable Cardioverter Defibrillator (WCD).
Interventions
- DEVICE ASSURE™ Wearable Cardioverter Defibrillator (WCD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2019-03-20 |
| Est. Completion | 2019-06-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03887052
The ClinicalTrials.gov registry entry for NCT03887052 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kestra Medical Technologies, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ASSURE™ Wearable Cardioverter Defibrillator (WCD) is the first listed.
NCT03887052 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03887052 about?
NCT03887052 is a clinical study titled "ASSURE WCD Clinical Evaluation - Detection and Safety Study". A prospective multicenter single arm open label study to evaluate ambulatory detection performance, arrhythmia detection and safety of the ASSURE™ Wearable Cardioverter Defibrillator (WCD).
What is the current status of trial NCT03887052?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2019-03-20. Estimated completion is 2019-06-18.
What interventions are being tested in trial NCT03887052?
The interventions under investigation include: ASSURE™ Wearable Cardioverter Defibrillator (WCD) (DEVICE).
Who is sponsoring clinical trial NCT03887052?
This trial is sponsored by Kestra Medical Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.